Breaking News
Get 40% Off 0
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool. See stock ideas
Close

Innovent Biologics Inc (1801)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.25 +0.75    +1.90%
23:43:07 - Delayed Data. Currency in HKD ( Disclaimer )
Type:  Equity
Market:  Hong Kong
ISIN:  KYG4818G1010 
  • Volume: 2,774,999
  • Bid/Ask: 40.15 / 40.25
  • Day's Range: 39.20 - 40.85
Innovent Biologics 40.25 +0.75 +1.90%

1801 Recent Sentiments

 
This page contains information on users’ sentiments for the Innovent Biologics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 03, 2024 สุชาติ เชี่ยวชาญไชยรั   43.00 Jan 03, 2024 @ 41.50 -3.49%
Jul 11, 2023 Антон Бутаков   30.05 Nov 30, 2023 @ 45.05 +49.92%
May 10, 2023 Andreas Schatz   38.80 Nov 30, 2023 @ 45.05 +16.11%
Dec 14, 2022 Дмитрий Стефанович   33.55 Dec 19, 2022 @ 31.35 -6.56%
Dec 13, 2022 Rostislav Shumilov   33.15 Jan 06, 2023 @ 33.80 +1.96%
Nov 15, 2022 Михаил Наймушин   34.35 Nov 15, 2022 @ 34.35 0.00%
Oct 18, 2022 Lei Chun   29.15 Oct 24, 2022 @ 27.15 -6.86%
Sep 01, 2022 Lei Chun   33.90 Sep 05, 2022 @ 29.90 -11.80%
Aug 22, 2022 Lei Chun   32.90 Aug 29, 2022 @ 32.80 -0.30%
Aug 09, 2022 Lei Chun   35.95 Aug 15, 2022 @ 36.70 +2.09%
Jul 27, 2022 Lei Chun   33.25 Aug 01, 2022 @ 32.75 -1.50%
Jun 28, 2022 Lei Chun   36.65 Jul 04, 2022 @ 38.00 +3.68%
Jun 14, 2022 Lei Chun   25.20 Jun 20, 2022 @ 26.95 +6.94%
Jun 08, 2022 Lei Chun   27.75 Jun 13, 2022 @ 25.80 -7.03%
Jun 01, 2022 Lei Chun   24.90 Jun 06, 2022 @ 26.05 +4.62%
May 16, 2022 Lei Chun   19.60 May 23, 2022 @ 22.55 +15.05%
May 04, 2022 Lei Chun   20.80 May 09, 2022 @ 19.64 -5.58%
Mar 29, 2022 Lei Chun   28.00 Apr 04, 2022 @ 29.05 +3.75%
Feb 15, 2022 Barbaro francisco...   32.30 Mar 11, 2022 @ 27.40 +15.17%
Feb 14, 2022 Jj Kkk   30.45 Mar 11, 2022 @ 27.40 -10.02%
Jan 06, 2022 Salvatore Fusco   39.05 Jan 28, 2022 @ 30.90 -20.87%
Oct 05, 2021 Grace Kim   74.15 Oct 29, 2021 @ 69.90 +5.73%
Jul 06, 2021 Derek L   89.00 Jul 30, 2021 @ 79.45 -10.73%
Jun 07, 2021 Derek L   87.95 Jul 02, 2021 @ 87.05 -1.02%
Apr 29, 2021 VRAQ   86.20 May 03, 2021 @ 85.05 -1.33%
Mar 31, 2021 vanessa lam   79.30 Apr 23, 2021 @ 90.15 +13.68%
Mar 04, 2021 Ho Hou   80.20 Mar 26, 2021 @ 75.40 -5.99%
Dec 29, 2020 Derek L   76.40 Jan 22, 2021 @ 99.35 +30.04%
Dec 08, 2020 Ryan Ryan Cheung   56.30 Jan 01, 2021 @ 82.05 +45.74%
Dec 03, 2020 Samuel Wong   53.90 Dec 25, 2020 @ 72.95 +35.34%
Dec 03, 2020 Samuel Wong   53.90 Dec 25, 2020 @ 72.95 +35.34%
Nov 25, 2020 Derek L   50.90 Dec 18, 2020 @ 67.40 +32.42%
Nov 10, 2020 Ryan Ryan Cheung   54.80 Dec 04, 2020 @ 57.50 -4.93%
Nov 09, 2020 Carlos Wong   55.25 Dec 04, 2020 @ 57.50 -4.07%
Oct 30, 2020 Carrie Yuen   58.45 Nov 20, 2020 @ 56.35 +3.59%
Oct 29, 2020 Keith Cheng   60.20 Nov 20, 2020 @ 56.35 -6.40%
Oct 06, 2020 Victor Kang   59.80 Oct 30, 2020 @ 57.20 -4.35%
Sep 29, 2020 Carrie Yuen   55.85 Oct 23, 2020 @ 64.00 -14.59%
Sep 28, 2020 Oscar Lo   56.95 Oct 23, 2020 @ 64.00 +12.38%
Sep 23, 2020 gary chung   63.00 Sep 23, 2020 @ 63.00 0.00%
Sep 16, 2020 Louis Liang   63.00 Oct 09, 2020 @ 60.85 -3.41%
Sep 07, 2020 Victor Kang   57.50 Oct 02, 2020 @ 57.40 -0.17%
Aug 26, 2020 태호 임   54.00 Sep 18, 2020 @ 62.40 +15.56%
Aug 24, 2020 Carrie Yuen   54.80 Aug 28, 2020 @ 57.00 +4.01%
Aug 10, 2020 Carrie Yuen   48.35 Aug 10, 2020 @ 48.35 0.00%
Aug 04, 2020 상희 이   48.30 Aug 05, 2020 @ 50.40 +4.35%
Jul 24, 2020 Samuel Wong   51.85 Aug 14, 2020 @ 50.35 -2.89%
Jul 16, 2020 서핑 워렌   50.20 Aug 07, 2020 @ 49.70 -1.00%
Jun 30, 2020 Kr Choi   56.85 Jul 24, 2020 @ 50.25 -11.61%
Jun 29, 2020 동근 김   57.15 Jun 29, 2020 @ 57.15 0.00%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

1801 Comments

Write your thoughts about Innovent Biologics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
JAME Megueni
VRAQ Feb 13, 2022 9:33PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
*M Stanley Trims INNOVENT BIO TP to $65, Rated Overweight
JAME Megueni
VRAQ Jan 24, 2022 9:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
UBS Axes INNOVENT BIO TP to $65, Rated Buy
JAME Megueni
VRAQ Jan 20, 2022 8:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
*HSBC Global Research Cuts INNOVENT BIO TP to $85, Rated Buy
JAME Megueni
VRAQ Aug 29, 2021 11:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
C Suisse Cuts INNOVENT BIO TP to $90; Rated Outperform
JAME Megueni
VRAQ Aug 23, 2021 12:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
M Stanley Assumes INNOVENT BIO Shr Hike in 15 Days; Rated Overweight
JAME Megueni
VRAQ Apr 28, 2021 4:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Daiwa Sees INNOVENT BIO as Sector Top-pick; 1Q Sintilimab Sales In Line
JAME Megueni
VRAQ Mar 07, 2021 9:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
UBS Lifts INNOVENT BIO TP to $132.9, Downgrades INNOCARE-B (09969.HK) to ***Neutral*** (Correct)
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email